Deutsche Bank Research Lowers Novo Nordisk's PT, Affirms Sell Rating

MT Newswires · 2d ago
08:29 AM EDT, 10/07/2026 (MT Newswires) -- Deutsche Bank Research on Tuesday reduced the price target for Danish pharmaceutical giant Novo Nordisk (NOVO-B.CO) to 225.00 Danish kroner from 245.00 kroner and kept its rating at sell. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)